<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39459912</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>10</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>08</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Mpox in East Africa: Learning from COVID-19 and Ebola to Strengthen Public Health Responses.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1578</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v16101578</ELocationID><Abstract><AbstractText>The Africa Centers for Disease Control and Prevention declared mpox a Public Health Emergency of Continental Security (PHECS) in Africa. African public health systems have moved to mobilize a response against a backdrop of inherent significant challenges. With this commentary, we discuss how lessons from past public health emergencies, particularly COVID-19 and Ebola outbreaks, have prepared the region for improved disease surveillance, rapid response strategies, and effective public health communication and how these lessons can be applied to the mpox response, emphasizing the importance of strong healthcare infrastructure, effective data sharing, community engagement, targeted interventions, and robust contact tracing. Additionally, addressing misinformation and building public trust are crucial for controlling the spread of any disease. By leveraging these strategies, African countries can enhance their response to mpox. This includes improving diagnostic capabilities, strengthening cross-border collaborations, and prioritizing vaccination campaigns where needed. Ultimately, by applying the hard-earned lessons from the COVID-19 pandemic and Ebola outbreak, the East Africa region can better address the challenges posed by mpox and safeguard public health.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gashema</LastName><ForeName>Pierre</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0001-9348-0936</Identifier><AffiliationInfo><Affiliation>Department of Research, Repolicy Research Centre, Kigali P.O. Box 7584, Rwanda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Genomic Biology, INES Ruhengeri, Ruhengeri P.O. Box 155, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musafiri</LastName><ForeName>Tumusime</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0001-5863-2818</Identifier><AffiliationInfo><Affiliation>Partners in Health, Kigali P.O. Box 3432, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ndahimana</LastName><ForeName>Felix</ForeName><Initials>F</Initials><Identifier Source="ORCID">0000-0003-4008-6286</Identifier><AffiliationInfo><Affiliation>Laboratory of Entomology, Wageningen University and Research, Droevendaalsesteeg 4, 6708 PB Wageningen, The Netherlands.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, University of Rwanda, Kigali P.O. Box 4285, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iradukunda</LastName><ForeName>Hyppolyte</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, University of Rwanda, Kigali P.O. Box 4285, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saramba</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0009-0003-3527-0262</Identifier><AffiliationInfo><Affiliation>Department of Research, Repolicy Research Centre, Kigali P.O. Box 7584, Rwanda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>College of Medicine and Health Sciences, University of Rwanda, Kigali P.O. Box 4285, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nyakatswau</LastName><ForeName>Stuart T</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Research and Development Department, Wastinnova Pvt Ltd., 5/39 Strachan St, Harare, Zimbabwe.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gahamanyi</LastName><ForeName>Noel</ForeName><Initials>N</Initials><Identifier Source="ORCID">0000-0001-7813-6440</Identifier><AffiliationInfo><Affiliation>Rwanda Biomedical Centre, Kigali P.O. Box 7162, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Iradukunda</LastName><ForeName>Patrick Gad</ForeName><Initials>PG</Initials><Identifier Source="ORCID">0000-0002-0236-7776</Identifier><AffiliationInfo><Affiliation>Department of Research, Repolicy Research Centre, Kigali P.O. Box 7584, Rwanda.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Drugs Department, Rwanda Food and Drugs Authority, Kigali P.O. Box 1948, Rwanda.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmed</LastName><ForeName>Ayman</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-9516-9508</Identifier><AffiliationInfo><Affiliation>Faculty of Science, University of Basel, Petersplatz 1, Basel P.O. Box 4001, Switzerland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Endemic Diseases, University of Khartoum, Khartoum 11111, Sudan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dzinamarira</LastName><ForeName>Tafadzwa</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9929-5739</Identifier><AffiliationInfo><Affiliation>ICAP Columbia University, Lusaka, Zambia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Health Systems and Public Health, University of Pretoria, Pretoria 0002, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Muvunyi</LastName><ForeName>Claude Mambo</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Rwanda Biomedical Centre, Kigali P.O. Box 7162, Rwanda.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019142" MajorTopicYN="Y">Hemorrhagic Fever, Ebola</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="Y">Public Health</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000351" MajorTopicYN="N" Type="Geographic">Africa, Eastern</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Ebola virus</Keyword><Keyword MajorTopicYN="N">epidemic</Keyword><Keyword MajorTopicYN="N">global health security</Keyword><Keyword MajorTopicYN="N">mpox vaccine</Keyword><Keyword MajorTopicYN="N">mpox virus</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">poxvirus</Keyword></KeywordList><CoiStatement>Author named Stuart T. Nyakatswau was employed by the company Wastinnova Pvt Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39459912</ArticleId><ArticleId IdType="pmc">PMC11512314</ArticleId><ArticleId IdType="doi">10.3390/v16101578</ArticleId><ArticleId IdType="pii">v16101578</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mpox (Formerly Monkeypox): Pathogenesis, Prevention and Treatment|Signal Transduction and Targeted Therapy.  [(accessed on 3 October 2024)].  Available online:  https://www.nature.com/articles/s41392-023-01675-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10751291</ArticleId><ArticleId IdType="pubmed">38148355</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-Country Monkeypox Outbreak in Non-Endemic Countries.  [(accessed on 24 September 2024)].  Available online:  https://www.who.int/emergencies/disease-outbreak-news/item/2022-DON385.</Citation></Reference><Reference><Citation>Virulence Differences of Mpox (Monkeypox) virus Clades I, IIa, and IIb.1 in a Small Animal Model—PubMed.  [(accessed on 2 October 2024)]; Available online:  https://pubmed.ncbi.nlm.nih.gov/36787354/</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9974501</ArticleId><ArticleId IdType="pubmed">36787354</ArticleId></ArticleIdList></Reference><Reference><Citation>Clade I Mpox in Central and Eastern Africa—Level 2—Practice Enhanced Precautions—Travel Health Notices|Travelers’ Health|CDC.  [(accessed on 2 October 2024)]; Available online:  https://wwwnc.cdc.gov/travel/notices/level2/clade-1-mpox-central-eastern-africa.</Citation></Reference><Reference><Citation>Sustained Human Outbreak of a New MPXV Clade I lineage in Eastern Democratic Republic of the Congo|Nature Medicine.  [(accessed on 2 October 2024)].  Available online:  https://www.nature.com/articles/s41591-024-03130-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11485229</ArticleId><ArticleId IdType="pubmed">38871006</ArticleId></ArticleIdList></Reference><Reference><Citation>Mpox—African Region.  [(accessed on 24 September 2024)].  Available online:  https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON528.</Citation></Reference><Reference><Citation>Van Dijck C., Hoff N.A., Mbala-Kingebeni P., Low N., Cevik M., Rimoin A.W., Kindrachuk J., Liesenborghs L. Emergence of mpox in the post-smallpox era—A narrative review on mpox epidemiology. Clin. Microbiol. Infect. 2023;29:1487–1492. doi: 10.1016/j.cmi.2023.08.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2023.08.008</ArticleId><ArticleId IdType="pubmed">37574113</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogunleye S.C., Akinsulie O.C., Aborode A.T., Olorunshola M.M., Gbore D., Oladoye M., Adesola R.O., Gbadegoye J.O., Olatoye B.J., Lawal M.A., et al. The re-emergence and transmission of Monkeypox virus in Nigeria: The role of one health. Front. Public Health. 2024;11:1334238. doi: 10.3389/fpubh.2023.1334238.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1334238</ArticleId><ArticleId IdType="pmc">PMC10797020</ArticleId><ArticleId IdType="pubmed">38249416</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC, “About Mpox,” Mpox.  [(accessed on 24 September 2024)]; Available online:  https://www.cdc.gov/mpox/about/index.html.</Citation></Reference><Reference><Citation>Musuka G., Moyo E., Tungwarara N., Mhango M., Pierre G., Saramba E., Iradukunda P.G., Dzinamarira T. A critical review of mpox outbreaks, risk factors, and prevention efforts in Africa: Lessons learned and evolving practices. IJID Reg. 2024;12:100402. doi: 10.1016/j.ijregi.2024.100402.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijregi.2024.100402</ArticleId><ArticleId IdType="pmc">PMC11326932</ArticleId><ArticleId IdType="pubmed">39157420</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaughan A.M., Cenciarelli O., Colombe S., de Sousa L.A., Fischer N., Gossner C.M., Pires J., Scardina G., Aspelund G., Avercenko M., et al. A large multi-country outbreak of monkeypox across 41 countries in the WHO European Region, 7 March to 23 August 2022. Eurosurveillance. 2022;27:2200620. doi: 10.2807/1560-7917.ES.2022.27.36.2200620.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.36.2200620</ArticleId><ArticleId IdType="pmc">PMC9461311</ArticleId><ArticleId IdType="pubmed">36082686</ArticleId></ArticleIdList></Reference><Reference><Citation>Mpox (Monkeypox)—Democratic Republic of the Congo.  [(accessed on 3 October 2024)].  Available online:  https://www.who.int/emergencies/disease-outbreak-news/item/2023-DON493.</Citation></Reference><Reference><Citation>Dukers-Muijrers N.H.T.M., Evers Y., Widdershoven V., Davidovich U., Adam P.C.G., de Coul E.L.M.O., Zantkuijl P., Matser A., Prins M., de Vries H.J.C., et al. Mpox vaccination willingness, determinants, and communication needs in gay, bisexual, and other men who have sex with men, in the context of limited vaccine availability in the Netherlands (Dutch Mpox-survey) Front. Public Health. 2023;10:1058807. doi: 10.3389/fpubh.2022.1058807.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.1058807</ArticleId><ArticleId IdType="pmc">PMC9850232</ArticleId><ArticleId IdType="pubmed">36684959</ArticleId></ArticleIdList></Reference><Reference><Citation>Attitudes towards Receiving Monkeypox Vaccination: A Systematic Review and Meta-Analysis—Abstract—Europe PMC.  [(accessed on 3 October 2024)].  Available online:  https://europepmc.org/article/MED/38140243.</Citation></Reference><Reference><Citation>Ogunkola I.O., Abiodun O.E., Bale B.I., Elebesunu E.E., Ujam S.B., Umeh I.C., Tom-James M., Musa S.S., Manirambona E., Evardone S.B., et al. Monkeypox vaccination in the global south: Fighting a war without a weapon. Clin. Epidemiol. Glob. Health. 2023;22:101313. doi: 10.1016/j.cegh.2023.101313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cegh.2023.101313</ArticleId><ArticleId IdType="pmc">PMC10195808</ArticleId><ArticleId IdType="pubmed">37220529</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Chen Z. Mpox: A review of laboratory detection techniques. Arch. Virol. 2023;168:221. doi: 10.1007/s00705-023-05848-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-023-05848-w</ArticleId><ArticleId IdType="pmc">PMC10404179</ArticleId><ArticleId IdType="pubmed">37543543</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Zhang E., Li W., Lv R., Lin Y., Xu Y., Li J., Lai Y., Jiang Y., Lin S., et al. Advances and challenges of monkeypox detection technology. Biosaf. Health. 2024 doi: 10.1016/j.bsheal.2024.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bsheal.2024.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Masirika L.M., Udahemuka J.C., Schuele L., Ndishimye P., Otani S., Mbiribindi J.B., Marekani J.M., Mambo L.M., Bubala N.M., Boter M., et al. Ongoing mpox outbreak in Kamituga, South Kivu province, associated with monkeypox virus of a novel Clade I sub-lineage, Democratic Republic of the Congo, 2024. Eurosurveillance. 2024;29:2400106. doi: 10.2807/1560-7917.ES.2024.29.11.2400106.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2024.29.11.2400106</ArticleId><ArticleId IdType="pmc">PMC10941309</ArticleId><ArticleId IdType="pubmed">38487886</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Urges Rapid Access to Mpox Diagnostic Tests, Invites Manufacturers to Emergency Review.  [(accessed on 3 October 2024)].  Available online:  https://www.who.int/news-room/29-08-2024-who-urges-rapid-access-to-mpox-diagnostic-tests--invites-manufacturers-to-emergency-review.</Citation></Reference><Reference><Citation>Alvarez E., Bielska I.A., Hopkins S., Belal A.A., Goldstein D.M., Slick J., Pavalagantharajah S., Wynfield A., Dakey S., Gedeon M.-C., et al. Limitations of COVID-19 testing and case data for evidence-informed health policy and practice. Health Res. Policy Syst. 2023;21:11. doi: 10.1186/s12961-023-00963-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12961-023-00963-1</ArticleId><ArticleId IdType="pmc">PMC9876649</ArticleId><ArticleId IdType="pubmed">36698202</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization [WHO]  Ebola Virus Disease.  [(accessed on 17 November 2021)].  Available online:  https://www.who.int/news-room/fact-sheets/detail/ebola-virus-disease.</Citation></Reference><Reference><Citation>Najimudeen M., Chen H.W.J., Jamaluddin N.A., Myint M.H., Marzo R.R. Monkeypox in Pregnancy: Susceptibility, Maternal and Fetal Outcomes, and One Health Concept. Int. J. Matern. Child Health AIDS (IJMA) 2022;11:e594. doi: 10.21106/ijma.594.</Citation><ArticleIdList><ArticleId IdType="doi">10.21106/ijma.594</ArticleId><ArticleId IdType="pmc">PMC9468204</ArticleId><ArticleId IdType="pubmed">36258711</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz D.A. High Rates of Miscarriage and Stillbirth among Pregnant Women with Clade I Mpox (Monkeypox) Are Confirmed during 2023–2024 DR Congo Outbreak in South Kivu Province. Viruses. 2024;16:1123. doi: 10.3390/v16071123.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v16071123</ArticleId><ArticleId IdType="pmc">PMC11281436</ArticleId><ArticleId IdType="pubmed">39066285</ArticleId></ArticleIdList></Reference><Reference><Citation>Rwanda’s New Mobile Lab That Will Boost COVID-19 Testing Capacity.  [(accessed on 3 October 2024)]; Available online:  https://www.moh.gov.rw/news-detail/rwandas-new-mobile-lab-that-will-boost-covid-19-testing-capacity.</Citation></Reference><Reference><Citation>New Technology Allows for Rapid Diagnosis of Ebola in Democratic Republic of the Congo|WHO|Regional Office for Africa.  [(accessed on 3 October 2024)].  Available online:  https://www.afro.who.int/news/new-technology-allows-rapid-diagnosis-ebola-democratic-republic-congo.</Citation></Reference><Reference><Citation>Nachega J.B., Mbala-Kingebeni P., Otshudiema J., Mobula L.M., Preiser W., Kallay O., Michaels-Strasser S., Breman J.G., Rimoin A.W., Nsio J., et al. Responding to the Challenge of the Dual COVID-19 and Ebola Epidemics in the Democratic Republic of Congo—Priorities for Achieving Control. Am. J. Trop. Med. Hyg. 2020;103:597–602. doi: 10.4269/ajtmh.20-0642.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.20-0642</ArticleId><ArticleId IdType="pmc">PMC7410434</ArticleId><ArticleId IdType="pubmed">32563272</ArticleId></ArticleIdList></Reference><Reference><Citation>Bosonkie M., Egbende L., Namale A., Fawole O.I., Seck I., Kizito S., Kaba D., Kiwanuka S.N., Diallo I., Bello S., et al. Improving testing capacity for COVID-19: Experiences and lessons from Senegal, Uganda, Nigeria, and the Democratic Republic of Congo. Front. Public Health. 2023;11:1202966. doi: 10.3389/fpubh.2023.1202966.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2023.1202966</ArticleId><ArticleId IdType="pmc">PMC10693422</ArticleId><ArticleId IdType="pubmed">38045972</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarki A.M., Ezeh A., Stranges S. Uganda as a Role Model for Pandemic is Containment in Africa. Am. J. Public Health. 2020;110:1800–1802. doi: 10.2105/AJPH.2020.305948.</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2020.305948</ArticleId><ArticleId IdType="pmc">PMC7661999</ArticleId><ArticleId IdType="pubmed">33180572</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoemaker T.R., Balinandi S., Tumusiime A., Nyakarahuka L., Lutwama J., Mbidde E., Kofman A., Klena J.D., Ströher U.E., Rollin P., et al. Impact of enhanced viral haemorrhagic fever surveillance on outbreak detection and response in Uganda. Lancet Infect. Dis. 2018;18:373–375. doi: 10.1016/s1473-3099(18)30164-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1473-3099(18)30164-6</ArticleId><ArticleId IdType="pmc">PMC5894352</ArticleId><ArticleId IdType="pubmed">29582758</ArticleId></ArticleIdList></Reference><Reference><Citation>Republic of Kenya Receives Mobile Labs from the EAC Secretariat.  [(accessed on 24 September 2024)].  Available online:  https://www.eac.int/press-releases/147-health/1730-republic-of-kenya-receives-mobile-labs-from-the-eac-secretariat.</Citation></Reference><Reference><Citation>Affara M., Lagu H.I., Achol E., Karamagi R., Omari N., Ochido G., Kezakarayagwa E., Kabatesi F., Nkeshimana A., Roba A., et al. The East African Community (EAC) mobile laboratory networks in Kenya, Burundi, Tanzania, Rwanda, Uganda, and South Sudan—From project implementation to outbreak response against Dengue, Ebola, COVID-19, and epidemic-prone diseases. BMC Med. 2021;19:160. doi: 10.1186/s12916-021-02028-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02028-y</ArticleId><ArticleId IdType="pmc">PMC8266482</ArticleId><ArticleId IdType="pubmed">34238298</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet T. Mpox: The need for a coordinated international response. Lancet. 2024;404:725. doi: 10.1016/S0140-6736(24)01708-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01708-2</ArticleId><ArticleId IdType="pubmed">39173642</ArticleId></ArticleIdList></Reference><Reference><Citation>Alakija A. Leveraging lessons from the COVID-19 pandemic to strengthen low-income and middle-income country preparedness for future global health threats. Lancet Infect. Dis. 2023;23:e310–e317. doi: 10.1016/S1473-3099(23)00279-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00279-7</ArticleId><ArticleId IdType="pubmed">37290474</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-Country Outbreak of Mpox, External Situation Report#30—25 November 2023.  [(accessed on 3 October 2024)].  Available online:  https://www.who.int/publications/m/item/multi-country-outbreak-of-mpox--external-situation-report-30---25-november-2023.</Citation></Reference><Reference><Citation>The 4 × 4 Reform: A Path to Quality Health Care in Rwanda.  [(accessed on 24 September 2024)]; Available online:  https://www.moh.gov.rw/news-detail/the-4x4-reform-a-path-to-quality-health-care-in-rwanda.</Citation></Reference><Reference><Citation>Branda F., Ceccarelli G., Ciccozzi M., Scarpa F. Strengthening community resilience: Lessons from COVID-19 for mpox prevention. Lancet. 2024;404:929. doi: 10.1016/S0140-6736(24)01752-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(24)01752-5</ArticleId><ArticleId IdType="pubmed">39182503</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlov M. Monkeypox outbreaks: 4 key questions researchers have. Nature. 2022;606:238–239. doi: 10.1038/d41586-022-01493-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-01493-6</ArticleId><ArticleId IdType="pubmed">35624160</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertran M., Andrews N., Davison C., Dugbazah B., Boateng J., Lunt R., Hardstaff J., Green M., Blomquist P., Turner C., et al. Effectiveness of one dose of MVA–BN smallpox vaccine against mpox in England using the case-coverage method: An observational study. Lancet Infect. Dis. 2023;23:828–835. doi: 10.1016/S1473-3099(23)00057-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00057-9</ArticleId><ArticleId IdType="pubmed">36924787</ArticleId></ArticleIdList></Reference><Reference><Citation>Multi-Country Monkeypox Outbreak Declared a Global Public Health Emergency of International Concern—Africa CDC.  [(accessed on 24 September 2024)].  Available online:  https://africacdc.org/news-item/multi-country-monkeypox-outbreak-declared-a-global-public-health-emergency-of-international-concern-2/</Citation></Reference><Reference><Citation>Scaling Up African Vaccine Manufacturing Capacity|Reports|Wellcome.  [(accessed on 24 September 2024)].  Available online:  https://wellcome.org/reports/scaling-african-vaccine-manufacturing-capacity.</Citation></Reference><Reference><Citation>Lamptey E., Senkyire E.K., Benita D.A., Boakye E.O. COVID-19 vaccines development in Africa: A review of current situation and existing challenges of vaccine production. Clin. Exp. Vaccine Res. 2022;11:82–88. doi: 10.7774/cevr.2022.11.1.82.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2022.11.1.82</ArticleId><ArticleId IdType="pmc">PMC8844666</ArticleId><ArticleId IdType="pubmed">35223668</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H., Zhang H., Ding K., Wang X.-H., Sun G.-Y., Liu Z.-X., Luo Y. The evolving epidemiology of monkeypox virus. Cytokine Growth Factor Rev. 2022;68:1–12. doi: 10.1016/j.cytogfr.2022.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2022.10.002</ArticleId><ArticleId IdType="pmc">PMC9547435</ArticleId><ArticleId IdType="pubmed">36244878</ArticleId></ArticleIdList></Reference><Reference><Citation>Mremi I.R., George J., Rumisha S.F., Sindato C., Kimera S.I., Mboera L.E.G. Twenty years of integrated disease surveillance and response in Sub-Saharan Africa: Challenges and opportunities for effective management of infectious disease epidemics. One Health Outlook. 2021;3:22. doi: 10.1186/s42522-021-00052-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42522-021-00052-9</ArticleId><ArticleId IdType="pmc">PMC8575546</ArticleId><ArticleId IdType="pubmed">34749835</ArticleId></ArticleIdList></Reference><Reference><Citation>Worsley-Tonks K.E.L., Bender J.B., Deem S.L., Ferguson A.W., Fèvre E.M., Martins D.J., Muloi D.M., Murray S., Mutinda M., Ogada D., et al. Strengthening global health security by improving disease surveillance in remote rural areas of low-income and middle-income countries. Lancet Glob. Health. 2022;10:e579–e584. doi: 10.1016/S2214-109X(22)00031-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2214-109X(22)00031-6</ArticleId><ArticleId IdType="pmc">PMC8923676</ArticleId><ArticleId IdType="pubmed">35303467</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngum N., Mashingia J., Ndomondo-Sigonda M., Walker S., Salek S. Evaluation of the Effectiveness and Efficiency of the East African Community Joint Assessment Procedure by Member Countries: The Way Forward. Front. Pharmacol. 2022;13:891506. doi: 10.3389/fphar.2022.891506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.891506</ArticleId><ArticleId IdType="pmc">PMC9294367</ArticleId><ArticleId IdType="pubmed">35865962</ArticleId></ArticleIdList></Reference><Reference><Citation>Diarra T., Onyeneho N., Okeibunor J., Dialloa B., Yao M.N.K., Djingarey M.H., Fall S., Chamla D., Gueye A.S. Response of Healthcare Service Providers to the Ebola Virus Disease Epidemic in the Democratic Republic of Congo’s North Kivu and Ituri Provinces. J. Immunol. Sci. 2023;S3:20–30. doi: 10.29245/2578-3009/2023/S3.1107.</Citation><ArticleIdList><ArticleId IdType="doi">10.29245/2578-3009/2023/S3.1107</ArticleId><ArticleId IdType="pmc">PMC7615614</ArticleId><ArticleId IdType="pubmed">38333361</ArticleId></ArticleIdList></Reference><Reference><Citation>Africa Health Workforce Investment Charter_v6_May 2023.pdf.  [(accessed on 24 September 2024)].  Available online:  https://www.afro.who.int/sites/default/files/2023-08/Africa%20Health%20Workforce%20Investment%20Charter_v6_May%202023.pdf.</Citation></Reference><Reference><Citation>Haldane V., De Foo C., Abdalla S.M., Jung A.-S., Tan M., Wu S., Chua A., Verma M., Shrestha P., Singh S., et al. Health systems resilience in managing the COVID-19 pandemic: Lessons from 28 countries. Nat. Med. 2021;27:964–980. doi: 10.1038/s41591-021-01381-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01381-y</ArticleId><ArticleId IdType="pubmed">34002090</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed A., Idris-Dantata H., Okwor T., Tanui P., Paintsil E., Kabwe P.C., Alimi Y., Tajudeen R., Mankoula W., Ilesanmi O.S., et al. Supporting the Manufacturing of Medical Supplies in Africa: Collaboration Between Africa CDC, Partners, and Member States. Glob. Health Sci. Pract. 2023;11:e2300121. doi: 10.9745/GHSP-D-23-00121.</Citation><ArticleIdList><ArticleId IdType="doi">10.9745/GHSP-D-23-00121</ArticleId><ArticleId IdType="pmc">PMC10615240</ArticleId><ArticleId IdType="pubmed">37903581</ArticleId></ArticleIdList></Reference><Reference><Citation>ABezruki, Moon S., editors. Global Health Centre Working Paper. Graduate Institute of International and Development Studies, Global Health Centre; Geneva, Switzerland: 2021. Always Fighting the Last War? Post-Ebola Reforms, Blindspots &amp; Gaps in COVID-19. No. 26/2021.</Citation></Reference><Reference><Citation>Dzinamarira T., Tungwarara N., Chitungo I., Chimene M., Iradukunda P.G., Mashora M., Murewanhema G., Rwibasira G.N., Musuka G. Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs. Vaccines. 2022;10:252. doi: 10.3390/vaccines10020252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10020252</ArticleId><ArticleId IdType="pmc">PMC8879800</ArticleId><ArticleId IdType="pubmed">35214710</ArticleId></ArticleIdList></Reference><Reference><Citation>Sørensen K., Van den Broucke S., Fullam J., Doyle G., Pelikan J., Slonska Z., Brand H., (HLS-EU) Consortium Health Literacy Project European Health literacy and public health: A systematic review and integration of definitions and models. BMC Public Health. 2012;12:80. doi: 10.1186/1471-2458-12-80.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-12-80</ArticleId><ArticleId IdType="pmc">PMC3292515</ArticleId><ArticleId IdType="pubmed">22276600</ArticleId></ArticleIdList></Reference><Reference><Citation>Filip R., Puscaselu R.G., Anchidin-Norocel L., Dimian M., Savage W.K. Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems. J. Pers. Med. 2022;12:1295. doi: 10.3390/jpm12081295.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jpm12081295</ArticleId><ArticleId IdType="pmc">PMC9409667</ArticleId><ArticleId IdType="pubmed">36013244</ArticleId></ArticleIdList></Reference><Reference><Citation>Nachega J.B., Mohr E.L., Dashraath P., Mbala-Kingebeni P., Anderson J.R., Myer L., Gandhi M., Baud D., Mofenson L.M., Muyembe-Tamfum J.-J. Mpox in Pregnancy—Risks, Vertical Transmission, Prevention, and Treatment. N. Engl. J. Med. 2024. Online ahead of print .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmp2410045</ArticleId><ArticleId IdType="pubmed">39197097</ArticleId></ArticleIdList></Reference><Reference><Citation>Muvunyi C.M., Bigirimana N., Tuyishime A., Mukagatare I., Ngabonziza J.C., Ahmed A. Initiatives and Strategies to Strengthen the National, Regional, and International Global Health Security: A Case Study of Rwanda Biomedical Centre. SSRN; Rochester, NY, USA: 2024. p. 4957490.</Citation><ArticleIdList><ArticleId IdType="doi">10.2139/ssrn.4957490</ArticleId></ArticleIdList></Reference><Reference><Citation>Remera E., Rwagasore E., Muvunyi C.M., Ahmed A. Emergence of the first molecularly confirmed outbreak of Rift Valley fever among humans in Rwanda, calls for institutionalizing the One Health strategy. IJID One Health. 2024;4:100035. doi: 10.1016/j.ijidoh.2024.100035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijidoh.2024.100035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed A., Daily J.P., Lescano A.G., Golightly L.M., Fasina A. Challenges and Strategies for Biomedical Researchers Returning to Low- and Middle-Income Countries after Training. Am. J. Trop. Med. Hyg. 2020;102:494–496. doi: 10.4269/ajtmh.19-0674.</Citation><ArticleIdList><ArticleId IdType="doi">10.4269/ajtmh.19-0674</ArticleId><ArticleId IdType="pmc">PMC7056415</ArticleId><ArticleId IdType="pubmed">31912776</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>